An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosen, 2007, Modelling breast cancer: One size does not fit all, Nat. Rev. Cancer, 7, 659, 10.1038/nrc2193
Holliday, 2011, Choosing the right cell line for breast cancer research, Breast Cancer Res., 13, 215, 10.1186/bcr2889
Eccles, 2013, Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer, Breast Cancer Res., 15, R92, 10.1186/bcr3493
Lacroix, 2004, Relevance of breast cancer cell lines as models for breast tumors: An update, Breast Cancer Res. Treat., 83, 249, 10.1023/B:BREA.0000014042.54925.cc
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., and Eccles, S.A. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol., 10.
Prat, 2013, Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes, Breast Cancer Res. Treat., 142, 237, 10.1007/s10549-013-2743-3
Neve, 2006, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, 10, 515, 10.1016/j.ccr.2006.10.008
Lim, 2009, Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat. Med., 15, 907, 10.1038/nm.2000
Shoemaker, 2006, The NCI60 human tumor cell line anticancer drug screen, Nat. Rev. Cancer, 6, 813, 10.1038/nrc1951
Monks, 1991, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst., 83, 757, 10.1093/jnci/83.11.757
Prat, 2011, Deconstructing the molecular portraits of breast cancer, Mol. Oncol., 5, 5, 10.1016/j.molonc.2010.11.003
Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. USA, 98, 10869, 10.1073/pnas.191367098
Hu, Z., Fan, C., Oh, D.S., Marron, J.S., He, X., Qaqish, B.F., Livasy, C., Carey, L.A., Reynolds, E., and Dressler, L. (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genom., 7.
Prat, 2010, Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Res., 12, R68, 10.1186/bcr2635
Mackay, 2009, A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines, Breast Cancer Res. Treat., 118, 481, 10.1007/s10549-008-0296-7
Kao, J., Salari, K., Bocanegra, M., Choi, Y.-L., Girard, L., Gandhi, J., Kwei, K.A., Hernandez-Boussard, T., Wang, P., and Gazdar, A.F. (2009). Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE, 4.
Ross, 2001, A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines, Dis. Mark., 17, 99, 10.1155/2001/850531
Parker, 2009, Supervised risk predictor of breast cancer based on intrinsic subtypes, J. Clin. Oncol., 27, 1160, 10.1200/JCO.2008.18.1370
Rocha, 2011, Distinct stem cells contribute to mammary gland development and maintenance, Nature, 479, 189, 10.1038/nature10573
Shehata, 2012, Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland, Breast Cancer Res., 14, R134, 10.1186/bcr3334
Granit, R.Z., Slyper, M., and Ben-Porath, I. (2014). Axes of Differentiation in Breast Cancer: Untangling Stemness, Lineage Identity, and the Epithelial to Mesenchymal Transition, John Wiley & Sons, Inc.. Wiley Interdisciplinary Reviews. Systems Biology and Medicine.
Chou, 2010, GATA3 in development and cancer differentiation: Cells GATA have it!, J. Cell. Physiol., 222, 42, 10.1002/jcp.21943
Kim, 2008, GATA-3 and the regulation of the mammary luminal cell fate, Curr. Opin. Cell Biol., 20, 164, 10.1016/j.ceb.2008.02.003
Douglas, 2013, The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer, J. Mammary Gland Biol. Neoplasia, 18, 143, 10.1007/s10911-013-9282-8
Bouras, 2008, Notch signaling regulates mammary stem cell function and luminal cell-fate commitment, Cell Stem Cell, 3, 429, 10.1016/j.stem.2008.08.001
Visvader, 2014, Mammary stem cells and the differentiation hierarchy: Current status and perspectives, Genes Dev., 28, 1143, 10.1101/gad.242511.114
Heiser, 2012, Subtype and pathway specific responses to anticancer compounds in breast cancer, Proc. Natl. Acad. Sci. USA, 109, 2724, 10.1073/pnas.1018854108
Niepel, 2013, Profiles of basal and stimulated receptor signaling networks predict drug response in breast cancer lines, Sci Signal., 6, ra84, 10.1126/scisignal.2004379
Liu, 2012, ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells, Am. J. Pathol., 180, 599, 10.1016/j.ajpath.2011.10.036
Ethier, 1993, Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media, Cancer Res., 53, 627
Ip, M.M., and Asch, B.B. (2000). Isolation and Culture of Human Breast Cancer Cells from Primary Tumors and Metastases. Methods in Mammary Gland Biology and Breast Cancer Research, Springer.
Wallden, B., Storhoff, J., Nielsen, T., Dowidar, N., Schaper, C., Ferree, S., Liu, S., Leung, S., Geiss, G., and Snider, J. (2015). Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med. Genom., 8.
Waltz, 2007, Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells, J. Steroid Biochem. Mole. Biol., 104, 11, 10.1016/j.jsbmb.2006.09.039
Du, 2010, Overexpression of DeltaNp63alpha induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway, Cancer Sci., 101, 2417, 10.1111/j.1349-7006.2010.01700.x
Subramanyam, 2011, Notch signaling pathway as a therapeutic target in breast cancer, Mol. Cancer Ther., 10, 9, 10.1158/1535-7163.MCT-10-0677
Ouzounova, 2015, Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Molecular Cancer, Therapeutics, 14, 779
Mohammed, 2015, Progesterone receptor modulates ERalpha action in breast cancer, Nature, 523, 313, 10.1038/nature14583
Zheng, 2005, A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells, J. Biol. Chem., 280, 17480, 10.1074/jbc.M501261200
Fan, 2004, TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines, Cancer Res., 64, 5132, 10.1158/0008-5472.CAN-04-0615
Fillmore, 2010, Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling, Proc. Natl. Acad. Sci. USA, 107, 21737, 10.1073/pnas.1007863107
Pendse, 2017, Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity, Arch. Toxicol., 91, 1749, 10.1007/s00204-016-1824-6
Stender, 2007, Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation, Mol. Endocrinol., 21, 2112, 10.1210/me.2006-0474
Frasor, 2003, Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype, Endocrinology, 144, 4562, 10.1210/en.2003-0567
Nagai, 2015, Gene Expression Profiles in Breast Cancer to Identify Estrogen Receptor Target Genes, Recent Adv. Med. Chem., 1, 381
Yamaga, 2013, RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites, Hormones Cancer, 4, 222, 10.1007/s12672-013-0140-3